tirzepatide vs semaglutide trial vs. for Patients with Obesity: A Head-to-Head https://jwat.ch/3ZijGUc Tirzepatide vs semaglutide and liraglutide

204 The combination of Cilofexor (an FXR agonist) and Firsocostat (an ACC inhibitor) has shown more effective in reducing the NA) ( p = 0.040) and minimizing dose-dependent complications of FXR activation (e.g., pruritus and LDL elevation) than Cilofexor used alone in patients with F3-F4 fibrosis or compensated cirrhosis in a phase 2b trial (NCT03449446)

Mahendra A

Both card types are accepted, and a letter of medical necessity is available on request to support reimbursement claims

Before we dive into how to navigate GLP-1 medications and intuitive eating, let's do a quick refresher on what intuitive eating is all about

doi: 10.1056/NEJMoa2410027 158 MalhotraAGrusteinRRFietzeIWeaverTERedlineSAzarbarzinAet al